MRD in AML: data from whole exome sequencing

Catia Patricia Simoes Pinto
csimoes.1@alumni.unav.es

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001006585	In our study, we hypothetyzed that CD34progenitors from cases with undetectable Minimal residual Disease (MRD) by flow cytometry would contain cells with leukemic-initiating-potential that could be identified on genetic (rather than phenotypic) grounds by Whole Exome Sequencing.	Illumina NovaSeq 6000	30